Open-house rebate agreement for Paliperidone depot formulations
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Paliperidon, in 3-Monats-Depot-Darreichungsformen, ATC N05AX13
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
48 / 100
Risk factors
Submitting documents in the wrong DTVP area is explicitly prohibited; the notice says the contract documents must not b...
To obtain contract start on the next month’s first day, complete and correct documents must be received by the 3rd of t...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2027
- Non-exclusive rebate agreement for pharmaceutical products: Paliperidone in 3-month depot dosage forms (ATC N05AX13).
- Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Show full summary
This is an open-house supply arrangement by AOK Bayern for Paliperidone in 3-month depot formulations (ATC N05AX13). It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 01.11.2025 to 31.10.2027, with contract entry possible at any time until 03.09.2027. Submission is electronic via DTVP with a qualified electronic signature or by signed paper originals in duplicate; German language is required, and non-German documents must include a German translation.
Risks
Submitting documents in the wrong DTVP area is explicitly prohibited; the notice says the contract documents must not b...
To obtain contract start on the next month’s first day, complete and correct documents must be received by the 3rd of t...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.
Eligibility
- Only pharmaceutical companies are eligible as potential contract partners.
Administrative
- A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open-house rebate agreement for Paliperidone depot formulations
Supply arrangement for Paliperidone in 3-month depot dosage forms (ATC N05AX13). The lot is an open-house rebate agreement, not a selective tender. Contract terms are pre-set and non-negotiable. Performance is in Germany, Bavaria (DE212).
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Paliperidon, in 3-Monats-Depot-Darreichungsformen, ATC N05AX13
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 14 Sep 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 602050-2025
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
48 / 100
Risk factors
Submitting documents in the wrong DTVP area is explicitly prohibited; the notice says the contract documents must not b...
To obtain contract start on the next month’s first day, complete and correct documents must be received by the 3rd of t...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications